Mysore, Keshava
Oxley, James D.
Duckham, Craig
Castilla-Gutierrez, Clarissa
Stewart, Akilah T. M.
Winter, Nikhella
Feng, Rachel Shui
Singh, Satish
James, Lester D.
Mohammed, Azad
Severson, David W.
Duman-Scheel, Molly
Funding for this research was provided by:
Innovative Vector Control Consortium
U.S. Department of Defense (W81XWH-17-1-0294)
Article History
Received: 11 June 2024
Accepted: 29 November 2024
First Online: 4 December 2024
Competing interests
: The funders of this work did not play a role in the design of this study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, nor in the decision to publish the results of this investigation. The opinions, interpretations, conclusions and recommendations are those of the manuscript’s authors and are not necessarily endorsed by the U.S. Army Medical Research Acquisition Activity. In the conduction of research utilizing recombinant DNA, the investigator adhered to NIH Guidelines for research involving recombinant DNA molecules. Although MDS and DWS are inventors on U.S. patent No: 62/361,704, European Application No. 17828458.4, which was filed by Indiana University, this did not affect their interpretations of the data presented in this manuscript and does not impact their adherence to journal policies on sharing data and materials. The research findings presented herein are not related to any products or services currently provided by any third parties. Although MDS is serving as a guest editor for the Vector Control for Neglected Diseases Collection, she had no involvement with the review of this manuscript at <i>Scientific Reports</i>. The other authors declare that they have no competing interests.